Dr Carver, Senior Vice President, R&D and Innovation, FUJIFILM Diosynth Biotechnologies, will be presented with the award and will give the Peter Dunnill Award lecture at the 12th Annual bioProcessUK Conference. This year’s conference, taking place on 25-26 November at the Wellcome Genome Campus (Hinxton, UK), will centre on the theme “Manufacturing Tomorrow’s Medicines Today.”
Mark was previously Chief Scientific Officer and Quality Director of Avecia Biologics Ltd. Prior to this he held a number of leading roles in Avecia and its predecessor companies, Zeneca and ICI, during a 27 year period in biotechnology R&D and R&D Management.
Mark has a number of external roles, helping to lead the development of biotechnology and bioprocessing science in the UK, including membership of the UK BioScience for Industry Strategy Panel and the Bioprocessing Research Industry Club (BRIC). He is also Chair of the UK BRIC Skills group and sits on the steering and advisory boards for a number of leading bioscience departments in UK universities. In addition to these roles, he was the recipient of the IChemE Donald Medal in 2012 for outstanding services to biochemical engineering.
Steve Bates, Chief Executive Officer, BIA, said: “I’m delighted that Mark has been selected as the seventh recipient of the Peter Dunnill Award, in recognition of his skill, passion and dedication to the bioprocessing industry. During the past decades, he has played a significant role in the UK bioprocessing sector which, with the continued support of individuals like Mark, continues to establish itself as a global leader.”
Dr Mark Carver, Senior Vice President R&D and Innovation, FUJIFILM Diosynth Biotechnologies, commented: “It is a real privilege to have been awarded this year’s Peter Dunnill Award and to be recognized alongside the many talented previous recipients. Professor Dunnill contributed a vast amount to UK bioprocessing and I am honoured to be presented with such a prestigious award.”